Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders
Status:
Completed
Trial end date:
2019-05-01
Target enrollment:
Participant gender:
Summary
A randomized controlled trial to assess clinically the efficacy of the selective ileum
spasmolytic mebeverine on daytime incontinence and nocturnal enuresis of orthotopic w-ileal
neobladders and quality of life effect within 1 year post-surgery.